Although most GBS carriers have no symptoms, GBS in pregnant women may cause bladder or urinary tract infections; infection of the womb; and stillbirth.
Up to 20% of pregnant women carry GBS in their vaginas during the last trimester, with the potential of infecting the fetus during birth.
Group B streptococcus (GBS) is a type of bacterial infection that can be found in a pregnant woman's vagina or rectum. This bacteria is normally found in the vagina and/or rectum of about 25 % of all healthy, adult women. Those women who test positive for GBS are said to be colonized. A mother can pass GBS to her baby during delivery. GBS is responsible for affecting about 1 in every 2,000 babies in the United States. Not every baby who is born to a mother who tests positive for GBS will become ill. Although GBS is rare in pregnant women, the outcome can be severe, and therefore physicians include testing as a routine part of prenatal care.
Infants born with congenital GBS infections are treated immediately with intravenous antibiotics.
s. agalactiae (GBS)
Pregnant women are more likely to transmit GBS to their fetuses if they previously delivered a GBS-infected baby; have a urinary tract infection caused by GBS; carry GBS late in pregnancy; or begin labor before 37 weeks of gestation
Most GBS-carriers are treated with intravenous antibiotics--from membrane rupture through labor--to prevent fetal transmission.
GBS disease, also known as Group B Streptococcus disease, is a bacterial infection caused by a type of bacteria called Streptococcus agalactiae. It can affect newborns, pregnant women, the elderly, and individuals with compromised immune systems. GBS disease can lead to serious complications such as sepsis, pneumonia, and meningitis if left untreated. Testing pregnant women for GBS colonization and providing antibiotics during labor can help prevent transmission to newborns.
Women should be tested for GBS between 35 and 37 weeks of pregnancy to determine whether the bacteria are likely to be present at delivery.
Group B strep (GBS) most often affects pregnant women, infants, the elderly, and chronically ill adults.
GBS-infected mothers are less likely to infect their newborns if treated with antibiotics during labor.
A GBS-carrier's risk of delivering an infected child decreases from one in 200 to one in 4,000 if she is treated with antibiotics.